Johns Hopkins ABX Guide
Moxidectin
INDICATIONS
FDA
FDA
- Treatment of onchocerciasis due to Onchocerca volvulus in patients > 12 years of age
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Second-line therapy for the management of Strongyloides stercoralis infections
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: December 8, 2019
Citation
Dzintars, Kathryn. "Moxidectin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2019. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540717/all/Moxidectin.
Dzintars K. Moxidectin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540717/all/Moxidectin. Accessed July 29, 2025.
Dzintars, K. (2019). Moxidectin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540717/all/Moxidectin
Dzintars K. Moxidectin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. [cited 2025 July 29]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540717/all/Moxidectin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Moxidectin
ID - 540717
A1 - Dzintars,Kathryn, Pharm.D., BCPS
Y1 - 2019/12/08/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540717/all/Moxidectin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
